Evidence map›Paper›PMID 18718541›Full record

ArticleNeuroImage2009

Artefactual subcortical hyperperfusion in PET studies normalized to global mean: lessons from Parkinson's disease.

Per Borghammer, Paul Cumming, Joel Aanerud, Albert Gjedde

Abstract read
PubMed Publisher
In one paragraph

Article in NeuroImage, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 2 pooled it
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 2 syntheses or guidelines pooled it, 83 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Quantification of indirect pathway inhibition by the adenosine A2a antagonist SYN115 in Parkinson disease.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2010
    Trial
  5. Article
  6. Review
  7. Neurology · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Dorsal striatal dopamine induces fronto-cortical hypoactivity and attenuates anxiety and compulsive behaviors in rats.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Per BorghammerPET Center, Aarhus University Hospital, Denmark. per@pet.auh.dk
Paul Cumming
Joel Aanerud
Albert Gjedde
Aarhus University Hospital · DKAarhus University · DKLudwig-Maximilians-Universität München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimRecent studies of Parkinson's disease (PD) report subcortical increases of cerebral blood flow (CBF) or cerebral metabolic rate of glucose (CMRglc), after conventional normalization to the global mean. However, if the global mean CBF or CMRglc is decreased in the PD group, this normalization necessarily generates artificial relative increases in regions unaffected by the disease. This potential bias may explain the reported subcortical increases in PD. To test this hypothesis, we performed simulations with manipulation and subsequently analysis of sets of quantitative CBF maps by voxel-based statistics. MATERIALS AND

methodsCBF images from 49 healthy volunteers were randomly assigned to four sets of two groups of 20 subjects. For each set, CBF images in one group were manipulated, while the other group served as controls. In the first simulation, an isolated cortical decrease was simulated. In the second simulation, focal increases in the globus pallidus and thalamus motor nuclei were simulated in addition to cortical decreases, thus emulating the putative metabolic pattern in PD. The data were analyzed with both the SSM method and a univariate statistical approach with normalization to either the global mean or to the white matter mean.

resultsIn Simulation I, global normalization robustly created artefactual subcortical increases, irrespective of analysis methodology. Simulation II demonstrated that an increased signal from the small subcortical structures involved in PD can probably not be detected with present instrumentation and typically-used sample sizes.

conclusionImposing focal decreases on cortical CBF in conjunction with global mean normalization gives rise to spurious relative CBF increases in all of the regions reported to be hyperactive in PD. Since no PET study has reported absolute increases of CBF or CMRglc in any subcortical region in PD, we conclude that the relative increases reported in some studies most likely arise from biased normalization to the global mean.

Indexed as

ArtifactsCerebrovascular CirculationAdultBrainFemaleHumansImage EnhancementImage Interpretation, Computer-AssistedMaleMiddle AgedParkinson DiseasePositron-Emission TomographyReference ValuesReproducibility of ResultsSensitivity and Specificity

Identifiers

PMID18718541
OpenAlexW2069817585

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.